Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-14-037560

Options or other derivatives

  • CEO disposed of 950,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

DEES H CRAIG · CEO

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2014-10-03 Other disposition : show line 1 in the form Stock Option (right to buy) −475,000 475,000 D
2014-10-03 Other disposition : show line 2 in the form Stock Option (right to buy) −475,000 475,000 D
Loading xslF345X03/doc1.xml…